Tech Company Inital Public Offerings
Esperion Therapeutics IPO
On 6/26/2013, Esperion Therapeutics went public.
Transaction Overview
Company Name
Announced On
6/26/2013
Transaction Type
IPO
Amount
$70,000,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
3891 Ranchero Dr. 150
Ann Arbor, MI 48108
USA
Ann Arbor, MI 48108
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Emerging pharmaceutical company company focused on the research, development & commercialization of therapies for statin-intolerant patients with elevated
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tim Mayleben
Chief Financial Officer
Rick Bartram
Chief Technical Officer
Ken Fiorelli
VP - Bus. Development
William Sasiela
VP - Regulatory Affairs
Ashley Hall
Browse more venture capital transactions:
Prev: 6/26/2013: Skyonic venture capital transaction
Next: 6/26/2013: IntroHive venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs